New York State Common Retirement Fund Dyne Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 24,973 shares of DYN stock, worth $314,160. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,973
Previous 24,973
-0.0%
Holding current value
$314,160
Previous $897,000
34.45%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding DYN
# of Institutions
213Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$101 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$92.9 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$92.8 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$84.3 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$80.3 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $651M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...